Short-and long-term safety of oral propranolol in the treatment of infantile hemangioma / 中华皮肤科杂志

ABSTRACT

Infantile hemangioma is the most common tumor in infancy,with an incidence of 4％-5％.According to the risk level,hemangioma is divided into 3 levelshigh risk,medium risk and low risk.At present,the first-line treatment of high-risk hemangioma is oral propranolol (β-receptor blockers).It has been 10 years since infantile hemangioma was treated with propranolol for the first time,and propranolol has been the drug of first-choice in systematic treatment due to its high efficacy and good safety,but its long-term adverse effect needs further evaluation.